RETRACTION: Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines (Retraction of Vol 8, art no E57020, 2013)

被引:1
|
作者
Wang, P.
Gao, Q.
Suo, Z.
Munthe, E.
Solberg, S.
Ma, L.
机构
来源
PLOS ONE | 2020年 / 15卷 / 04期
关键词
D O I
10.1371/journal.pone.0232726
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] RETRACTION: Apoptotic Effects of Rotundic Acid upon Human Esophagus and Lung Cancer Cells (Retraction of Vol 18, art no 1534735416635275, 2019)
    Lin, Yu-sen
    Hu, Lihong
    Yin, Mei-chin
    INTEGRATIVE CANCER THERAPIES, 2016, 18
  • [22] IDENTIFICATION OF CANCER STEM CELLS IN OSTEOSARCOMA CELL LINES: CHARACTERIZATION OF CANCER STEM CELL MARKERS EXPRESSION AND IN VIVO TUMORIGENICITY
    Skoda, J.
    Neradil, J.
    Zambo, I.
    Hermanova, M.
    Sterba, J.
    Veselska, R.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S269 - S269
  • [23] RETRACTION: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy (Retraction of Vol 8, art no E55790, 2013)
    Yan, Lei
    Xing, Zhaoquan
    Guo, Zhaoxin
    Fang, Zhiqing
    Jiao, Wei
    Guo, Xiaoyu
    Xu, Zhonghua
    Fang, Zhenghui
    Liu, Zhaoxu
    PLOS ONE, 2024, 19 (02):
  • [24] RETRACTION: Thyroid Cancer Cell Resistance to Gefitinib Depends on the Constitutive Oncogenic Activation of the ERK Pathway (Retraction of Vol 98, art no 2502, 2013)
    Frasca, F.
    Vella, V.
    Nicolosi, M. L.
    Messina, R. L.
    Giani, F.
    Lotta, S.
    Vigneri, P.
    Regalbuto, C.
    Vigneri, R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (05): : E207 - E207
  • [25] RETRACTION: Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer (Retraction of Vol 8, art no E66275, 2013)
    Ma, J.
    Xue, Y.
    Liu, W.
    Yue, C.
    Bi, F.
    Xu, J.
    PLOS ONE, 2020, 15 (10):
  • [26] Brefeldin A Inhibits Cancer Stem Cell Properties in Human Lung Cancer Cells
    Tseng, Chao-Neng
    Cho, Chung-Lung
    Chen, Tzan-Wen
    Chiu, Chien-Chih
    Chang, Hsueh-Wei
    Chang, Fang-Rong
    Chang, Yung-Fu
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2013, 8 (02) : 113 - 118
  • [27] RETRACTION: Nek6 Mediates Human Cancer Cell Transformation and Is a Potential Cancer Therapeutic Target (Retraction of Vol 8, Pg 717, 2010)
    Nassirpour, R.
    Shao, L.
    Flanagan, P.
    Abrams, T.
    Jallal, B.
    Smeal, T.
    MOLECULAR CANCER RESEARCH, 2017, 15 (03) : 358 - 358
  • [29] RETRACTION: Evaluation of Tegaran Formula ZhenHua cytotoxicity against human cancer cell lines (Retraction of Vol 15, Pg 40969, 2020)
    Parsonidis, P.
    Vlachou, I
    Mamagkaki, A.
    Bouris, I
    Daikopoulou, V
    Papasotiriou, I
    PLOS ONE, 2023, 18 (03):
  • [30] Utilization of lung cancer cell lines for the study of lung cancer stem cells
    Wang, Yuyi
    Jiang, Ming
    Du, Chi
    Yu, Yang
    Liu, Yanyang
    Li, Mei
    Luo, Feng
    ONCOLOGY LETTERS, 2018, 15 (05) : 6791 - 6798